 |
| |
| Feb-15-19 | Initiated |
Jefferies |
Buy |
$35 |
|
| Oct-23-18 | Resumed |
Raymond James |
Strong Buy |
$30 |
|
| Sep-18-18 | Reiterated |
H.C. Wainwright |
Neutral |
$17 → $22 |
|
| Nov-27-17 | Initiated |
H.C. Wainwright |
Buy |
$12 |
|
| Jun-14-16 | Reiterated |
Mizuho |
Buy |
$12 → $8 |
|
| Sep-29-15 | Downgrade |
Raymond James |
Outperform → Mkt Perform |
|
|
| Sep-25-15 | Initiated |
Craig Hallum |
Buy |
|
|
| Mar-18-15 | Reiterated |
Mizuho |
Buy |
$15 → $12 |
|
|
|
| Feb-14-19 08:00AM | CareDx to Announce Fourth Quarter 2018 Financial Results on March 6th, 2019 GlobeNewswire |
| Feb-13-19 07:03AM | This stock picker continues to outperform by using volatility as a friend MarketWatch |
| Feb-07-19 11:08AM | Read This Before Buying CareDx, Inc (NASDAQ:CDNA) Shares Simply Wall St. |
| Feb-06-19 08:00AM | CareDx to Participate in BTIG 6th Annual Medical Technology, Life Science Tools and Diagnostics Conference GlobeNewswire |
| Jan-09-19 08:00AM | CareDx to Present New AlloSure® Data at American Society of Transplant Surgeons Winter Symposium GlobeNewswire |
| Jan-07-19 08:00AM | CareDx Reports Preliminary Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire |
| Jan-03-19 08:35AM | CareDx Sees Hammer Chart Pattern: Time to Buy? Zacks -5.71% |
| Jan-02-19 11:10AM | Best Sector of 2018 and its Hit ETFs & Stocks Zacks |
| 09:02AM | Does The CareDx, Inc (NASDAQ:CDNA) Share Price Fall With The Market? Simply Wall St. |
| Dec-20-18 07:00AM | New Data on AlloSure Confirms Its Clinical Utility in Repeat Kidney Transplant Recipients GlobeNewswire -9.43% |
| Dec-18-18 04:11PM | IBD Stock Of The Day Nears Profitability As Revenue Spikes Investor's Business Daily |
| Dec-17-18 04:01PM | CareDx Director Dr. Amy Abernethy Resigns Board Seat to Become Principal Deputy Commissioner of the FDA GlobeNewswire -11.15% |
| 01:36AM | Do Hedge Funds Love CareDx, Inc. (CDNA)? Insider Monkey |
| Nov-28-18 08:25AM | New Research: Key Drivers of Growth for Mersana Therapeutics, Maiden, Payment Data, CareDx, Natera, and Spero Therapeutics Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire |
| Nov-26-18 04:01PM | CareDx Strengthens Executive Leadership Team with the Appointment of Reginald Seeto, MB.BS, as President and Chief Business Officer GlobeNewswire |
| 11:25AM | What Kind Of Shareholder Appears On The CareDx Incs (NASDAQ:CDNA) Shareholder Register? Simply Wall St. |
| 08:00AM | CareDx Announces Full Repayment of its Outstanding Debt GlobeNewswire |
| Nov-16-18 04:01PM | CareDx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire |
| Nov-15-18 11:27PM | Edited Transcript of CDNA earnings conference call or presentation 8-Nov-18 9:30pm GMT Thomson Reuters StreetEvents +12.50% |
| Nov-13-18 11:19PM | CareDx Announces Pricing of Public Offering of Common Stock GlobeNewswire -7.41% |
| 04:01PM | CareDx Announces Proposed Public Offering of Common Stock GlobeNewswire |
| Nov-08-18 06:20PM | CareDx (CDNA) Reports Q3 Loss, Tops Revenue Estimates Zacks |
| 05:14PM | CareDx: 3Q Earnings Snapshot Associated Press |
| 04:01PM | CareDx Reports Third Quarter Results GlobeNewswire |
| Nov-07-18 08:00AM | CareDx to Participate in Upcoming Investor Conferences GlobeNewswire |
| Nov-01-18 02:46PM | Harry Boxers four stocks to watch this week MarketWatch |
| 11:28AM | CareDx (CDNA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks |
| Oct-18-18 07:55AM | Market Trends Toward New Normal in LSC Communications, Corindus Vascular Robotics, Sprouts Farmers Market, Luminex, ChromaDex, and CareDx Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire |
| Oct-17-18 08:00AM | CareDx to Announce Third Quarter 2018 Financial Results on November 8, 2018 GlobeNewswire +6.88% |
| Oct-02-18 08:00AM | CareDx Profiles AlloSeq Suite of NGS Products at ASHI GlobeNewswire -7.91% |
| Sep-21-18 08:00AM | CareDx to Participate in Upcoming Investor Conference GlobeNewswire |
| Sep-18-18 11:10AM | CareDx Inc (NASDAQ:CDNA): Are Analysts Optimistic? Simply Wall St. |
| Sep-17-18 08:00AM | CareDx broadens HeartCare availability GlobeNewswire |
| Sep-07-18 03:57PM | Stock Market Forecast: More Gains, More Volatility Investor's Business Daily |
| Aug-27-18 07:45AM | Edited Transcript of CDNA earnings conference call or presentation 9-Aug-18 8:30pm GMT Thomson Reuters StreetEvents |
| Aug-24-18 08:10AM | Factors of Influence in 2018, Key Indicators and Opportunity within Seres Therapeutics, Barnes & Noble, Carbo Ceramics, BioLife Solutions, CareDx, and Syntel New Research Emphasizes Economic Growth GlobeNewswire |
| Aug-15-18 09:00AM | CareDx to Participate in Upcoming Investor Conference GlobeNewswire |
| Aug-10-18 08:07PM | Here's Why CareDx Jumped 13.5% Today Motley Fool +13.49% |
| 07:38AM | The Daily Biotech Pulse: Puma, CareDx Soar On Earnings, Corcept Plunges On Bottom-Line Miss Benzinga |
| Aug-09-18 07:40PM | CareDX stock soars nearly 20% after earnings MarketWatch |
| 06:00PM | CareDx (CDNA) Reports Q2 Loss, Tops Revenue Estimates Zacks |
| 04:58PM | CareDx: 2Q Earnings Snapshot Associated Press |
| 04:01PM | CareDx Reports Second Quarter Results GlobeNewswire |
| Jul-16-18 08:00AM | CareDx to Announce Second Quarter 2018 Financial Results on August 9, 2018 GlobeNewswire |
| Jun-28-18 08:00AM | Flatiron Health CMO/CSO Joins CareDx Board of Directors GlobeNewswire +5.08% |
| Jun-22-18 02:55PM | Here's Why CareDx Dropped Today Motley Fool -9.45% |
| Jun-21-18 07:40AM | Free Technical Reports on Myriad Genetics and Three Additional Services Equities ACCESSWIRE |
| Jun-19-18 09:00AM | CareDx set to join Russell 2000, Russell 3000 and Russell Microcap Indexes GlobeNewswire |
| 08:10AM | New Research: Key Drivers of Growth for New Mountain Finance, Chicago Rivet & Machine, Caseys General Stores, Great Western, Capstead Mortgage, and CareDx Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire |
| Jun-05-18 08:00AM | CareDx Promotes Living Donor Transplantation Through Employee Policy GlobeNewswire +11.56% |
| Jun-01-18 08:00AM | Key CareDx Events Scheduled at American Transplant Congress 2018 GlobeNewswire |
| May-24-18 08:00AM | CareDx to Hold Press Conference at American Transplant Congress GlobeNewswire |
| May-17-18 05:34PM | Edited Transcript of CDNA earnings conference call or presentation 10-May-18 8:30pm GMT Thomson Reuters StreetEvents |
| May-15-18 12:02PM | Best Growth Stocks To Buy Now Simply Wall St. |
| May-10-18 05:31PM | CareDx: 1Q Earnings Snapshot Associated Press |
| 04:01PM | CareDx Reports First Quarter Results GlobeNewswire |
| May-09-18 08:00AM | CareDx expands NGS Transplant Product Offerings GlobeNewswire |
| May-01-18 08:00AM | CareDx Activities at American Transplant Congress GlobeNewswire +5.11% |
| Apr-25-18 07:40AM | Free Post Earnings Research Report: CareDxs Quarterly Sales Rose 15%; Adjusted Net Loss Narrowed ACCESSWIRE |
| Apr-20-18 08:00AM | CareDx to Announce First Quarter 2018 Financial Results on May 10, 2018 GlobeNewswire |
| Apr-18-18 08:00AM | CareDx Closes Debt Refinancing GlobeNewswire |
| Apr-13-18 08:00AM | Olerup QTYPE® Receives CE Mark Certification GlobeNewswire |
| Apr-10-18 08:00AM | CareDx Launches HeartCare® for Heart Transplant Recipients GlobeNewswire |
| Apr-04-18 07:00AM | Wired News Myriad Genetics Receives Japanese Regulatory Approval for BRACAnalysis(R) Diagnostic System ACCESSWIRE +6.12% |
| Mar-29-18 08:00AM | CareDx Announces Completion of Debt Conversion GlobeNewswire |
| Mar-23-18 07:11PM | Edited Transcript of CDNA earnings conference call or presentation 22-Mar-18 8:30pm GMT Thomson Reuters StreetEvents +25.75% |
| Mar-22-18 04:42PM | CareDx reports 4Q loss Associated Press |
| 04:01PM | CareDx Reports Fourth Quarter and FY2017 Financial Results GlobeNewswire |
| 12:00PM | CareDx, Inc. to Host Earnings Call ACCESSWIRE |
| Mar-06-18 08:00AM | CareDx to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on March 22, 2018 GlobeNewswire |
| Mar-01-18 07:30AM | CareDx to Refinance Debt with Perceptive Advisors GlobeNewswire |
| Feb-27-18 08:25AM | Analysis: Positioning to Benefit within AZZ, Brink's, CareDx, Kinsale Capital Group, Wingstop, and Ambac Financial Group Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire |
| Feb-07-18 08:00AM | CareDx to Participate in Upcoming Investor Conferences GlobeNewswire |
| Feb-05-18 09:00AM | CareDx Leadership in cfDNA Highlighted at CEoT GlobeNewswire |
| Feb-01-18 08:00AM | First Patient Enrolled in AlloSure Registry GlobeNewswire |
| Jan-16-18 09:00AM | TRIO Honors Peter Maag with Transplant Innovation Award GlobeNewswire -8.02% |
| Jan-08-18 08:30AM | CareDx Reports Preliminary Fourth Quarter and FY2017 Financial Results GlobeNewswire |
| Dec-29-17 10:44AM | CORRECTING and REPLACING - Market Trends Toward New Normal in MDU Resources Group, TerraForm Global, CareDx, Kinsale Capital Group, UMB Financial, and Greif Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire |
| Dec-28-17 12:04PM | CORRECTING and REPLACING - Market Trends Toward New Normal in MDU Resources Group, TerraForm Global, CareDx, Kinsale Capital Group, UMB Financial, and Greif Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire |
| 08:00AM | Market Trends Toward New Normal in MDU Resources Group, TerraForm Global, CareDx, Kinsale Capital Group, UMB Financial, and Greif Bros. Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire |
| Dec-11-17 10:13AM | Here's Why You Should Steer Clear of LifePoint (LPNT) Stock Zacks |
| Dec-07-17 09:26AM | The Zacks Analyst Blog Highlights: Aetna, CareDx, PRA Health Sciences and Diplomat Pharmacy Zacks |
| Dec-06-17 01:07PM | 4 Attractive Stocks to Buy in an Evolving Healthcare Space Zacks |
| Dec-01-17 09:02AM | The Zacks Analyst Blog Highlights: BioLife Solutions, SeaSpine Holdings, Apollo Endosurgery and CareDx Zacks |
| Nov-30-17 02:54PM | 4 Top-Ranked Growth Stocks in MedTech Under $20 Zacks |
| Nov-27-17 12:38PM | ETFs with exposure to CareDx, Inc. : November 27, 2017 Capital Cube +10.00% |
| Nov-20-17 08:00AM | CMS Releases 2018 Clinical Laboratory Fee Schedule GlobeNewswire |
| Nov-17-17 11:33AM | ETFs with exposure to CareDx, Inc. : November 17, 2017 Capital Cube |
| Nov-16-17 12:31AM | Edited Transcript of CDNA earnings conference call or presentation 9-Nov-17 9:30pm GMT Thomson Reuters StreetEvents |
| Nov-15-17 09:00AM | CareDx Further Simplifies its Balance Sheet GlobeNewswire |
| 08:49AM | Teladoc Rides on Growing Demand for Telehealth Services Zacks |
| Nov-13-17 09:21AM | CareDx, Inc. :CDNA-US: Earnings Analysis: Q3, 2017 By the Numbers : November 13, 2017 Capital Cube |
| Nov-09-17 04:16PM | CareDx reports 3Q loss Associated Press |
| 04:02PM | CareDx Reports Third Quarter 2017 Financial Results GlobeNewswire |
| 12:30PM | CareDx, Inc. to Host Earnings Call ACCESSWIRE |
| Nov-07-17 09:54AM | ETFs with exposure to CareDx, Inc. : November 7, 2017 Capital Cube |
| Nov-02-17 09:00AM | CareDx to Participate in Upcoming Investor Conferences GlobeNewswire |
| Oct-31-17 09:00AM | CareDx Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire |
| Oct-30-17 08:00AM | AlloSure data will be presented at ASN GlobeNewswire |
| Oct-27-17 09:00AM | CareDx to Announce Third Quarter 2017 Financial Results on November 9, 2017 GlobeNewswire |
|
|
|
|
| CareDx, Inc., a transplant diagnostics company, together with its subsidiaries, engages in the discovery, development, and commercialization of diagnostic surveillance solutions for transplant patients worldwide. It operates through two segments, Post-Transplant Diagnostics and Pre-Transplant Diagnostics. The Post-Transplant Diagnostics segment develops and provides a diagnostic surveillance testing solution for heart and kidney transplant recipients. It offers AlloMap, a heart transplant molecular test; and AlloSure, a donor-derived cell free DNA test initially used for kidney transplant patients. The Pre-Transplant Diagnostics segment develops, manufactures, markets, and sells products that increase the chance of successful transplants by facilitating a match between a donor and a recipient of stem cells and organs. It sells Olerup SSP, which is used to type human leukocyte antigen (HAL) alleles based on sequence-specific primer technology; Olerup QTYPE, a test kit for sequence based HLA typing; Olerup SBT, a test kit for sequence based HLA typing; and XM-ONE, a test that identifies a patient's antigens against HLA Class I or Class II, as well as antibodies against a donor's endothelium. This segment offers its products directly to customers, as well as through third-party distributors. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. CareDx, Inc. was incorporated in 1998 and is headquartered in Brisbane, California. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Yee James P | Chief Medical Officer | Feb 12 | Option Exercise | 3.84 | 7,298 | 27,995 | 77,192 | Feb 13 09:38 PM | | Yee James P | Chief Medical Officer | Feb 12 | Sale | 23.88 | 32,500 | 776,100 | 44,692 | Feb 13 09:38 PM | | Abernethy Amy | Director | Jan 22 | Option Exercise | 12.88 | 5,000 | 64,400 | 15,837 | Jan 23 09:44 PM | | King Sasha | Chief Commercial Officer | Jan 02 | Option Exercise | 2.80 | 4,556 | 12,757 | 60,932 | Jan 04 04:19 PM | | King Sasha | Chief Commercial Officer | Dec 26 | Option Exercise | 1.66 | 2,834 | 4,692 | 56,376 | Dec 26 08:06 PM | | Maag Peter | See Remarks | Nov 29 | Sale | 28.59 | 7,831 | 223,898 | 400,541 | Nov 30 09:38 PM | | Maag Peter | See Remarks | Nov 28 | Sale | 28.52 | 92,169 | 2,628,614 | 408,372 | Nov 30 09:38 PM | | Maag Peter | See Remarks | Nov 21 | Option Exercise | 3.60 | 110,794 | 398,795 | 500,541 | Nov 21 05:37 PM | | Maag Peter | See Remarks | Nov 13 | Sale | 26.48 | 50,000 | 1,323,945 | 389,747 | Nov 15 09:55 PM | | Gagnon Neil | 10% Owner | Oct 31 | Sale | 27.05 | 108,599 | 2,937,331 | 107,940 | Nov 02 04:16 PM | | King Sasha | Chief Commercial Officer | Oct 05 | Sale | 24.60 | 11,500 | 282,900 | 53,542 | Oct 09 07:23 PM | | Bell Michael Brian | Chief Financial Officer | Sep 13 | Sale | 25.06 | 16,355 | 409,920 | 52,238 | Sep 13 08:26 PM | | Maag Peter | See Remarks | Sep 04 | Sale | 23.10 | 15,000 | 346,542 | 439,747 | Sep 04 09:25 PM | | Cohen Fred E | Director | Aug 28 | Option Exercise | 1.22 | 15,000 | 18,300 | 52,901 | Aug 29 06:09 PM | | Bell Michael Brian | Chief Financial Officer | Aug 14 | Sale | 16.84 | 12,500 | 210,463 | 68,593 | Aug 14 04:41 PM | | King Sasha | Chief Commercial Officer | Aug 01 | Option Exercise | 1.03 | 6,458 | 6,648 | 74,500 | Aug 01 07:32 PM | | King Sasha | Chief Commercial Officer | Aug 01 | Sale | 14.03 | 9,458 | 132,735 | 65,042 | Aug 01 07:32 PM | | Nelles Mitchell J | Chief Operating Officer | Jul 02 | Option Exercise | 4.25 | 31,899 | 135,649 | 126,538 | Jul 03 05:43 PM | | Nelles Mitchell J | Chief Operating Officer | Jul 02 | Sale | 12.48 | 39,649 | 494,911 | 86,889 | Jul 03 05:43 PM | | GAGNON NEIL | 10% Owner | Apr 26 | Buy | 9.42 | 10,136 | 95,481 | 965,894 | Apr 30 05:48 PM | | Maag Peter | See Remarks | Mar 27 | Sale | 7.87 | 15,000 | 118,035 | 272,037 | Mar 28 04:46 PM | | Maag Peter | See Remarks | Mar 20 | Option Exercise | 0.55 | 50,000 | 27,400 | 287,037 | Mar 21 06:00 PM |
|
|
|
|
|
|
